Global Viral Vectors Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Viral Vectors
    1.2 Classification of Viral Vectors by Type
        1.2.1 Overview: Global Viral Vectors Market Size by Type: 2020 Versus 2021 Versus 2026
        1.2.2 Global Viral Vectors Revenue Market Share by Type in 2020
        1.2.3 Retroviral Vectors
        1.2.4 Lentiviral Vectors
        1.2.5 Adenoviral Vectors
        1.2.6 Herpes Simplex Virus Vectors
        1.2.7 Chimeric Viral Vectors
        1.2.8 Others
    1.3 Global Viral Vectors Market by Application
        1.3.1 Overview: Global Viral Vectors Market Size by Application: 2020 Versus 2021 Versus 2026
        1.3.2 Cancers
        1.3.3 Inherited Disorders
        1.3.4 Viral Infections
        1.3.5 Others
    1.4 Global Viral Vectors Market Size & Forecast
    1.5 Global Viral Vectors Market Size and Forecast by Region
        1.5.1 Global Viral Vectors Market Size by Region: 2016 VS 2021 VS 2026
        1.5.2 Global Viral Vectors Market Size by Region, (2016-2021)
        1.5.3 North America Viral Vectors Market Size and Prospect (2016-2026)
        1.5.4 Europe Viral Vectors Market Size and Prospect (2016-2026)
        1.5.5 Asia-Pacific Viral Vectors Market Size and Prospect (2016-2026)
        1.5.6 South America Viral Vectors Market Size and Prospect (2016-2026)
        1.5.7 Middle East and Africa Viral Vectors Market Size and Prospect (2016-2026)
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Viral Vectors Market Drivers
        1.6.2 Viral Vectors Market Restraints
        1.6.3 Viral Vectors Trends Analysis
2 Company Profiles
    2.1 BioReliance
        2.1.1 BioReliance Details
        2.1.2 BioReliance Major Business
        2.1.3 BioReliance Viral Vectors Product and Solutions
        2.1.4 BioReliance Viral Vectors Revenue, Gross Margin and Market Share (2019-2021)
        2.1.5 BioReliance Recent Developments and Future Plans
    2.2 Cobra Biologics
        2.2.1 Cobra Biologics Details
        2.2.2 Cobra Biologics Major Business
        2.2.3 Cobra Biologics Viral Vectors Product and Solutions
        2.2.4 Cobra Biologics Viral Vectors Revenue, Gross Margin and Market Share (2019-2021)
        2.2.5 Cobra Biologics Recent Developments and Future Plans
    2.3 Oxford BioMedica
        2.3.1 Oxford BioMedica Details
        2.3.2 Oxford BioMedica Major Business
        2.3.3 Oxford BioMedica Viral Vectors Product and Solutions
        2.3.4 Oxford BioMedica Viral Vectors Revenue, Gross Margin and Market Share (2019-2021)
        2.3.5 Oxford BioMedica Recent Developments and Future Plans
    2.4 UniQure
        2.4.1 UniQure Details
        2.4.2 UniQure Major Business
        2.4.3 UniQure Viral Vectors Product and Solutions
        2.4.4 UniQure Viral Vectors Revenue, Gross Margin and Market Share (2019-2021)
        2.4.5 UniQure Recent Developments and Future Plans
    2.5 FinVector
        2.5.1 FinVector Details
        2.5.2 FinVector Major Business
        2.5.3 FinVector Viral Vectors Product and Solutions
        2.5.4 FinVector Viral Vectors Revenue, Gross Margin and Market Share (2019-2021)
        2.5.5 FinVector Recent Developments and Future Plans
    2.6 MolMed
        2.6.1 MolMed Details
        2.6.2 MolMed Major Business
        2.6.3 MolMed Viral Vectors Product and Solutions
        2.6.4 MolMed Viral Vectors Revenue, Gross Margin and Market Share (2019-2021)
        2.6.5 MolMed Recent Developments and Future Plans
    2.7 MassBiologics
        2.7.1 MassBiologics Details
        2.7.2 MassBiologics Major Business
        2.7.3 MassBiologics Viral Vectors Product and Solutions
        2.7.4 MassBiologics Viral Vectors Revenue, Gross Margin and Market Share (2019-2021)
        2.7.5 MassBiologics Recent Developments and Future Plans
    2.8 Richter-Helm
        2.8.1 Richter-Helm Details
        2.8.2 Richter-Helm Major Business
        2.8.3 Richter-Helm Viral Vectors Product and Solutions
        2.8.4 Richter-Helm Viral Vectors Revenue, Gross Margin and Market Share (2019-2021)
        2.8.5 Richter-Helm Recent Developments and Future Plans
    2.9 FUJIFILM Diosynth Biotechnologies
        2.9.1 FUJIFILM Diosynth Biotechnologies Details
        2.9.2 FUJIFILM Diosynth Biotechnologies Major Business
        2.9.3 FUJIFILM Diosynth Biotechnologies Viral Vectors Product and Solutions
        2.9.4 FUJIFILM Diosynth Biotechnologies Viral Vectors Revenue, Gross Margin and Market Share (2019-2021)
        2.9.5 FUJIFILM Diosynth Biotechnologies Recent Developments and Future Plans
    2.10 Lonza 
        2.10.1 Lonza Details
        2.10.2 Lonza Major Business
        2.10.3 Lonza Viral Vectors Product and Solutions
        2.10.4 Lonza Viral Vectors Revenue, Gross Margin and Market Share (2019-2021)
        2.10.5 Lonza Recent Developments and Future Plans
    2.11 Aldevron
        2.11.1 Aldevron Details
        2.11.2 Aldevron Major Business
        2.11.3 Aldevron Viral Vectors Product and Solutions
        2.11.4 Aldevron Viral Vectors Revenue, Gross Margin and Market Share (2019-2021)
        2.11.5 Aldevron Recent Developments and Future Plans
    2.12 Eurogentec
        2.12.1 Eurogentec Details
        2.12.2 Eurogentec Major Business
        2.12.3 Eurogentec Viral Vectors Product and Solutions
        2.12.4 Eurogentec Viral Vectors Revenue, Gross Margin and Market Share (2019-2021)
        2.12.5 Eurogentec Recent Developments and Future Plans
    2.13 Cell and Gene Therapy Catapult
        2.13.1 Cell and Gene Therapy Catapult Details
        2.13.2 Cell and Gene Therapy Catapult Major Business
        2.13.3 Cell and Gene Therapy Catapult Viral Vectors Product and Solutions
        2.13.4 Cell and Gene Therapy Catapult Viral Vectors Revenue, Gross Margin and Market Share (2019-2021)
        2.13.5 Cell and Gene Therapy Catapult Recent Developments and Future Plans
    2.14 Biovian
        2.14.1 Biovian Details
        2.14.2 Biovian Major Business
        2.14.3 Biovian Viral Vectors Product and Solutions
        2.14.4 Biovian Viral Vectors Revenue, Gross Margin and Market Share (2019-2021)
        2.14.5 Biovian Recent Developments and Future Plans
    2.15 Thermo Fisher Scientific (Brammer Bio)
        2.15.1 Thermo Fisher Scientific (Brammer Bio) Details
        2.15.2 Thermo Fisher Scientific (Brammer Bio) Major Business
        2.15.3 Thermo Fisher Scientific (Brammer Bio) Viral Vectors Product and Solutions
        2.15.4 Thermo Fisher Scientific (Brammer Bio) Viral Vectors Revenue, Gross Margin and Market Share (2019-2021)
        2.15.5 Thermo Fisher Scientific (Brammer Bio) Recent Developments and Future Plans
    2.16 VGXI
        2.16.1 VGXI Details
        2.16.2 VGXI Major Business
        2.16.3 VGXI Viral Vectors Product and Solutions
        2.16.4 VGXI Viral Vectors Revenue, Gross Margin and Market Share (2019-2021)
        2.16.5 VGXI Recent Developments and Future Plans
    2.17 PlasmidFactory
        2.17.1 PlasmidFactory Details
        2.17.2 PlasmidFactory Major Business
        2.17.3 PlasmidFactory Viral Vectors Product and Solutions
        2.17.4 PlasmidFactory Viral Vectors Revenue, Gross Margin and Market Share (2019-2021)
        2.17.5 PlasmidFactory Recent Developments and Future Plans
3 Market Competition, by Players
    3.1 Global Viral Vectors Revenue and Share by Players (2019-2021)
    3.2 Market Concentration Rate
        3.2.1 Top 3 Viral Vectors Players Market Share
        3.2.2 Top 10 Viral Vectors Players Market Share
        3.2.3 Market Competition Trend
    3.3 Viral Vectors Players Head Office, Products and Services Provided
    3.4 Mergers & Acquisitions
    3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
    4.1 Global Viral Vectors Revenue and Market Share by Type (2016-2021)
    4.2 Global Viral Vectors Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
    5.1 Global Viral Vectors Revenue Market Share by Application (2016-2021)
    5.2 Viral Vectors Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
    6.1 North America Viral Vectors Revenue by Type (2016-2026)
    6.2 North America Viral Vectors Revenue by Application (2016-2026)
    6.3 North America Viral Vectors Market Size by Country
        6.3.1 North America Viral Vectors Revenue by Country (2016-2026)
        6.3.2 United States Viral Vectors Market Size and Forecast (2016-2026)
        6.3.3 Canada Viral Vectors Market Size and Forecast (2016-2026)
        6.3.4 Mexico Viral Vectors Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
    7.1 Europe Viral Vectors Revenue by Type (2016-2026)
    7.2 Europe Viral Vectors Revenue by Application (2016-2026)
    7.3 Europe Viral Vectors Market Size by Country
        7.3.1 Europe Viral Vectors Revenue by Country (2016-2026)
        7.3.2 Germany Viral Vectors Market Size and Forecast (2016-2026)
        7.3.3 France Viral Vectors Market Size and Forecast (2016-2026)
        7.3.4 United Kingdom Viral Vectors Market Size and Forecast (2016-2026)
        7.3.5 Russia Viral Vectors Market Size and Forecast (2016-2026)
        7.3.6 Italy Viral Vectors Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
    8.1 Asia-Pacific Viral Vectors Revenue by Type (2016-2026)
    8.2 Asia-Pacific Viral Vectors Revenue by Application (2016-2026)
    8.3 Asia-Pacific Viral Vectors Market Size by Region
        8.3.1 Asia-Pacific Viral Vectors Revenue by Region (2016-2026)
        8.3.2 China Viral Vectors Market Size and Forecast (2016-2026)
        8.3.3 Japan Viral Vectors Market Size and Forecast (2016-2026)
        8.3.4 South Korea Viral Vectors Market Size and Forecast (2016-2026)
        8.3.5 India Viral Vectors Market Size and Forecast (2016-2026)
        8.3.6 Southeast Asia Viral Vectors Market Size and Forecast (2016-2026)
        8.3.7 Australia Viral Vectors Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
    9.1 South America Viral Vectors Revenue by Type (2016-2026)
    9.2 South America Viral Vectors Revenue by Application (2016-2026)
    9.3 South America Viral Vectors Market Size by Country
        9.3.1 South America Viral Vectors Revenue by Country (2016-2026)
        9.3.2 Brazil Viral Vectors Market Size and Forecast (2016-2026)
        9.3.3 Argentina Viral Vectors Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
    10.1 Middle East & Africa Viral Vectors Revenue by Type (2016-2026)
    10.2 Middle East & Africa Viral Vectors Revenue by Application (2016-2026)
    10.3 Middle East & Africa Viral Vectors Market Size by Country
        10.3.1 Middle East & Africa Viral Vectors Revenue by Country (2016-2026)
        10.3.2 Turkey Viral Vectors Market Size and Forecast (2016-2026)
        10.3.3 Saudi Arabia Viral Vectors Market Size and Forecast (2016-2026)
        10.3.4 UAE Viral Vectors Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
    12.1 Methodology
    12.2 Research Process and Data Source
    12.3 Disclaimer